CanadaBis Capital (CANB) AI Stock Analysis

• Market Cap: C$6.22M
• Dividend Yield: N/A
• Average Volume (3M): 52.13K
• Price to Earnings (P/E): 90.0
• Beta (1Y): -0.32
• Revenue Growth: -8.84%
• EPS Growth: -96.82%
• Country: CA
• Employees: N/A
• Sector: Financial
• Sector Strength: 74
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.00
• Shares Outstanding: 138,256,380
• 10 Day Avg. Volume: 43,590
• 30 Day Avg. Volume: 52,128
• PEG Ratio: -1.25
• Price to Book (P/B): 0.72
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.99
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 43 Neutral
• Price Target: C$0.00 ▼(-100.00%Downside)

CanadaBis Capital's overall stock score reflects significant financial challenges, including negative cash flow and high leverage. While technical analysis and valuation indicate bearish trends and overvaluation, recent corporate events provide a glimmer of hope through strategic initiatives and financing efforts.

CanadaBis Capital Business Overview & Revenue Model

Company Description

CanadaBis Capital Inc. is a diversified cannabis company operating in Canada, focusing on the cultivation, production, and distribution of cannabis and cannabis-related products. The company is actively involved in the cannabis sector through its various business segments, which include the production of premium cannabis strains and the development of cannabis derivatives and infused products. It aims to capitalize on the growing cannabis industry by leveraging its expertise in cultivation and processing.

How the Company Makes Money

CanadaBis Capital Inc. generates revenue primarily through the sale of its cannabis products, which include dried flower, oils, and derivative products such as edibles and concentrates. The company's revenue streams are bolstered by its cultivation facilities and processing capabilities, which enable it to produce high-quality cannabis products at scale. In addition to direct sales to consumers and medical patients, CanadaBis Capital also engages in wholesale transactions with other licensed producers and retailers. Key partnerships with distributors and retailers enhance its market reach and contribute significantly to its earnings.

CanadaBis Capital Financial Statement Overview

Summary

CanadaBis Capital's financial health is under pressure with declining revenue growth, a low net profit margin, high leverage, and negative cash flow metrics. Despite a reasonable gross profit margin, these factors indicate significant challenges in financial stability and performance.

Income Statement

CanadaBis Capital's income statement shows a mixed performance. The company has experienced a decline in revenue, with a revenue growth rate of -4.41% in the TTM. Gross profit margin is healthy at 46.16%, but net profit margin is very low at 0.41%, indicating challenges in converting revenue into net income. The EBIT margin of 2.62% and EBITDA margin of 9.00% suggest limited operational efficiency and profitability.

Balance Sheet

The balance sheet presents moderate financial stability. The debt-to-equity ratio is high at 1.06, indicating significant leverage and potential risk. The equity ratio stands at 34.66%, providing a moderate cushion against liabilities. Return on equity (ROE) is low at 0.81%, reflecting limited returns generated on shareholders' equity.

Cash Flow

Cash flow analysis reveals concerns with a negative free cash flow and a substantial drop in operating cash flow. The free cash flow growth rate is significantly negative, and both the operating cash flow to net income ratio and free cash flow to net income ratio indicate challenges in cash generation relative to earnings.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	17.95M	22.22M	11.67M	6.87M	4.43M
Gross Profit	8.82M	11.78M	5.57M	2.52M	1.16M
EBITDA	2.09M	5.68M	1.63M	-1.81M	-4.43M
Net Income	600.28K	4.44M	608.33K	-2.68M	-5.39M
Balance Sheet
Total Assets	24.55M	22.96M	15.48M	13.28M	12.52M
Cash, Cash Equivalents and Short-Term Investments	1.68M	3.23M	144.88K	849.50K	167.00K
Total Debt	6.44M	7.31M	7.82M	8.44M	6.06M
Total Liabilities	16.45M	15.62M	12.84M	11.46M	9.09M
Stockholders Equity	8.00M	7.25M	2.54M	1.73M	3.34M
Cash Flow
Free Cash Flow	-594.48K	4.57M	-292.54K	-1.96M	-8.58M
Operating Cash Flow	-256.31K	5.55M	-82.77K	-1.81M	-3.62M
Investing Cash Flow	-328.33K	-965.82K	-209.77K	122.77K	-2.39M
Financing Cash Flow	-962.02K	-1.50M	-412.09K	2.37M	5.85M

CanadaBis Capital Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.82 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CANB.

CanadaBis Capital Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	C$15.19B	6.82	23.28%	5.39%	33.61%	-23.38%
IMCC	57 Neutral	$8.67M	―	-63.75%	―	9.34%	69.69%
CANB	43 Neutral	C$6.22M	90.00	0.83%	―	-8.84%	-96.82%
PCLO	24 Underperform	$8.15M	―	184.66%	―	125.70%	47.09%

CanadaBis Capital Corporate Events

CanadaBis Capital Achieves Positive Q3 2025 Financial Results Amid Market Challenges

CanadaBis Capital has reported its financial results for Q3 2025, achieving a positive adjusted EBITDA of $440,665 despite a challenging market environment. The company recorded gross sales of $5.5 million and a 6% increase in gross earnings over previous periods. Strategic cost management and product innovation, including the launch of diamond and Keef-coated pre-rolls, have been pivotal in maintaining operational efficiency. Additionally, CanadaBis has reduced its short-term debt by $2.5 million and plans to launch innovative vape hardware later this year, positioning itself for future growth in the cannabis sector.

CanadaBis Capital Ends Arrangement Agreement with Simply Solventless

CanadaBis Capital Inc. has terminated its Arrangement Agreement with Simply Solventless Concentrates Ltd., which was intended for SSC to acquire all issued and outstanding shares of CanadaBis. The decision to terminate was due to a ‘Material Adverse Change’ concerning SSC, deemed in the best interest of CanadaBis shareholders and stakeholders. Consequently, all voting and support agreements related to the transaction have been automatically terminated, and a special meeting of CanadaBis shareholders has been canceled.